# Cipla Limited - Inspection Records

Source: https://www.globalkeysolutions.net/companies/cipla-limited/de9dc5de-fbea-4a7d-ab5b-a398b6ed442e

> Inspection records and compliance data for Cipla Limited in Pithampur, District Dhar, None. Access full analysis and detailed observations.

---

## Details

- Name: Cipla Limited
- FEI Number: 3008581988
- City: Pithampur, District Dhar
- State: None
- Country Name: India
- Address Line 1: Plot No. 9 & 10, Pharma Zone Phase Ii, Section Iiii, Indore Special Economic Zone
- Zip Code: None
- Business Operations: FDF MANUFACTURE

## Related Documents

- [483 - Cipla Limited - 2023-02-17](https://www.globalkeysolutions.net/records/483/cipla-limited/0c4d85ed-d21a-4440-8835-7e2f111667e9) — source: FDA, date: February 17, 2023
- [WARNING_LETTER - Cipla Limited - 2023-02-17](https://www.globalkeysolutions.net/records/warning_letter/cipla-limited/4a179ebd-255d-4805-a6d2-4e500633be4e) — source: FDA, date: February 17, 2023
- [483 - Cipla Limited - 2023-02-17](https://www.globalkeysolutions.net/records/483/cipla-limited/72954a77-6423-4064-b768-46c816145d00) — source: FDA, date: February 17, 2023
- [FDA Inspection 1198343 - Cipla Limited - 2023-02-17](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/69b7c844-7159-454b-b581-1a728cf834a1) — classification: Official Action Indicated (OAI), source: FDA, date: February 17, 2023
- [483 - Cipla Limited - 2022-07-01](https://www.globalkeysolutions.net/records/483/cipla-limited/606c0e82-5b62-4d28-bbe3-aa7eac7ea30d) — source: FDA, date: July 1, 2022
- [483 - Cipla Limited - 2022-07-01](https://www.globalkeysolutions.net/records/483/cipla-limited/e750f894-9f13-49ce-b379-c89e481f5245) — source: FDA, date: July 1, 2022
- [WARNING_LETTER - Cipla Limited - 2019-09-27](https://www.globalkeysolutions.net/records/warning_letter/cipla-limited/6321f828-da26-4571-b32c-638dd2cf14df) — source: FDA, date: September 27, 2019
- [FDA Inspection 1094880 - Cipla Limited - 2019-05-17](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/9cea89ef-a0a5-4ff4-ab9f-9fa0b8013aa8) — classification: No Action Indicated (NAI), source: FDA, date: May 17, 2019
- [483 - Cipla Limited - 2018-04-13](https://www.globalkeysolutions.net/records/483/cipla-limited/c8ec2a41-eca9-41c6-8e7d-d507b965a6dc) — source: FDA, date: April 13, 2018
- [FDA Inspection 1048005 - Cipla Limited - 2018-04-13](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/e8143ba3-08be-4081-940c-dd76d60ee6da) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 13, 2018
- [FDA Inspection 940719 - Cipla Limited - 2015-08-07](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/fa72598b-cff1-41a6-914e-bc9c8737e92c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 7, 2015
- [FDA Inspection 821114 - Cipla Limited - 2013-03-01](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/bb9a7048-5936-437d-b621-a16d6317cf46) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 1, 2013
- [FDA Inspection 806838 - Cipla Limited - 2012-11-02](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/78379ee7-9bf8-4cc2-977e-c2560781fac2) — classification: No Action Indicated (NAI), source: FDA, date: November 2, 2012

## Related Companies

- [McNeil Healthcare, LLC](https://www.globalkeysolutions.net/companies/mcneil-healthcare-llc/5f388817-1e62-4133-bd19-17b205bff73c)
- [Jubilant Generics Limited](https://www.globalkeysolutions.net/companies/jubilant-generics-limited/0e33a821-8bc0-4f36-9264-5a108f087380)
- [Maiva Pharma Private Limited](https://www.globalkeysolutions.net/companies/maiva-pharma-private-limited/3231d685-f5ad-401e-b1ae-66c6a6d8e8b7)
- [Janssen Ortho LLC](https://www.globalkeysolutions.net/companies/janssen-ortho-llc/d7bbb024-09b4-42ae-bbc5-fad0986f12c6)
- [InvaTech Pharma Solutions, LLC](https://www.globalkeysolutions.net/companies/invatech-pharma-solutions-llc/a4957f07-dcf0-47ec-a41a-7effe7e4a8e3)
- [Gilead Sciences, Inc.](https://www.globalkeysolutions.net/companies/gilead-sciences-inc/aef302cf-d6ca-423c-8e9a-4529b8be42ea)
- [Novartis Pharmaceuticals Corporation](https://www.globalkeysolutions.net/companies/novartis-pharmaceuticals-corporation/21559fd5-35ed-4cbd-b228-623dd76bcf47)
- [Ipca Laboratories Limited](https://www.globalkeysolutions.net/companies/ipca-laboratories-limited/4221e8f5-a261-45fc-b9fc-d935bc1f225b)
- [Recipharm Monts](https://www.globalkeysolutions.net/companies/recipharm-monts/e3b2f0c3-26eb-4020-8127-76127e9e18d6)
- [Kite Pharma, Inc.](https://www.globalkeysolutions.net/companies/kite-pharma-inc/5bf88060-db53-466b-9a1c-85be7984894f)

## Related Officers

- [Patric C. Klotzbuecher](https://www.globalkeysolutions.net/people/patric-c-klotzbuecher/cbb2e6b5-b001-457e-9073-33535f02926e)
- [Director](https://www.globalkeysolutions.net/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)
- [Dipesh K. Shah](https://www.globalkeysolutions.net/people/dipesh-k-shah/d4df4040-13d1-477b-8c21-4c8e5b3fc5b9)